Bangladesh's first homegrown Covid-19 vaccine to start human trials
Published: Jul 18, 2022 10:10 PM | Updated: Jul 19, 2022 1:40 AM
Bangladesh's first homegrown Covid-19 vaccine has obtained clearance for human trials in phase I, reported Xinhua.
The Bangavax vaccine, developed by local pharmaceutical company Globe Biotech, on Sunday received clearance from the Directorate-General of Drug Administration under the Ministry of Health and Family Welfare after the relevant authorities reviewed all the documents on all the previous trials.
"We've gotten the approval for...
View Comments0
Report this comment
500 characters remaining
Are you sure you want to delete this comment?
This action cannot be undone.